Regional brain atrophy in idiopathic parkinson’s disease and diffuse lewy body disease

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 6, 1996, Pages 304-313

  Double, K L ^a   Halliday, G M ^a   McRitchie, D A ^a   Reid, W G J ^b   Hely, M A ^b   Morris, J G L ^b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Brain volume; Cortical neuropathology; Frontal lobe; Medial temporal lobe

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DOPAMINERGIC NERVE CELL; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ATROPHY; BRAIN; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; ORGAN SIZE; PARKINSON DISEASE; REFERENCE VALUES; TEMPORAL LOBE;

EID: 0029839838     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106896     Document Type: Article

References (52)

1. Marsdcn CD: Parkinson's disease. J Neurol Neurosurg Psychiatry 1994:57:672-681.
2. Gibb WRG: Dementia and Parkinson's disease. BrJ Psychiatry 1989:154:596-614.
3. Reid WGJ: The evolution of dementia in idiopathic Parkinson's disease: Neuropsychological and clinical evidence in support of sub-types. Int Psychogeriatr 1992:4(suppl 2): 147-160.
4. Caparros-Lcfebvrc D, Pecheux N, Petit V, Duhamel A, Petit M: Which factors predict cognitive decline in Parkinson's disease? J Neurol Neurosurg Psychiatry 1995;58:51-55.
5. Stem Y, Richards M, Sano M, Mayeux R: Comparison of cognitive changes in patients with Alzheimer’s and Parkinson’s disease. Arch Neurol 1993;50:1040-1045.
6. Pillon B, Dubois B, Cusimano G, Bonnet A-M, Lhermitte F, Agid Y: Docs cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry 1989:52:201-206.
7. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV: Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor diability. Brain 1991; 114:2095- 2122.
8. Litvan I, Mohr E, Williams J, Gomez C, Chase TN: Differential memory and executive functions in demented patients with Parkinson’s and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1991;54:25-29.
9. Fischer P, Gatterer G, Simanyi M, Jellingcr K, Marterer A, Daniclczyk K, Daniclczyk W: Memory deficits in advanced Parkinson's disease. J Neural Transm 1990;2:59-70.
10. Hughes AJ, Daniel SE, Blankson S, Lees AJ: A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 1993;50:140-148.
11. Duyckaerts C, Gaspar P, Costa C, Bonnet A-M, Hauw J-J: Dementia in Parkinson's disease. Morphometrie data. Adv Neurol 1993;60:447-455.
12. Yoshimura M: Pathological basis for dementia in elderly patients with idiopathic Parkinson’s disease. Eur Neurol 1988;28(suppl 1):29-35.
13. Perry EK, Morris CM, Court JA, Cheng A, Fairbaim AF, McKeith IG, Irving D, Brown A, Perry RH: Alterations in nicotine binding sites in Parkinson’s disease, Lewy body dementia and Alzheimer’s disease: Possible index of early neuropathology. Neuroscience 1995:64:385-395.
14. Hansen LA, Galasko D: Lewy body disease. Curr Opin Neurol Neurosurg 1992;5:889-894.
15. Lippa CF, Smith TW, Swearer JM: Alzheimer’s disease and Lewy body disease: A comparative clinicopalhological study. Ann Neurol 1994;35:81-88.
16. Sugiyanta H, Hainfellner JA, Yoshimura M, Budka H: Ncocortical changes in Parkinson’s disease revisited. Clin Ncuropathol 1994;13: 55-59.
17. Gentleman SM, Williams B, Royston MC, Ja-goe R. Clinton J, Perry RH, Ince PG, Allsop D, Polak JM, Roberts GW: Quantification of PA4 protein deposition in the medial temporal lobe: a comparison of Alzheimer’s disease and senile dementia of the Lewy body type. Neurosci Lett 1992;142:9-12.
18. Halliday GM, McRitchic DA, Cartwright HR, Pamphlctt RS, Hely MA, Morris JGL: Pattern of midbrain neuropathology in different parkinsonian syndromes. J Clin Ncurosci 1996;3: 52-60.
19. Double KL, Halliday GM, Krill JJ, Harasty JA, Cullen K, Brooks WS, Crcasey H, Broc GA: Topography of brain atrophy during normal aging and Alzheimer's disease. Ncurobiol Aging, in press.
20. Louis ED, Goldman JE, Powers JM, Faltn S: Parkinsonian features of eight pathologically diagnosed cases of difTusc Lewy body disease. Mov Disord 1995;10:188-194.
21. Hely MA, Morris JGL, Rail D, Reid WGJ, O'Sullivan DJ, Williamson PM, Gcnge S, Broe GA: The Sydney multicentre study of Parkinson's disease: A report on the first 3 years. J Neurol Neurosurg Psychiatry 1989;52:324-328.
22. Hely MA, Morris JGL, Reid WGJ, O’Sullivan DJ, Williamson PM, Rail D, Broe GA, Margie S: The Sydney multicentre study of Parkinson's disease: A randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. J Neurol Neurosurg Psychiatry 1994;57:903-910.
23. Reid WGJ, Broc GA, Hcly MA, Morris JGL, Williamson PM, O’Sullivan DJ, Rail D, Gcnge SA, Moss NG: The neuropsychology of de novo patients with idiopathic Parkinson’s disease: the effects of age of onset. Int J Ncurosci 1989; 48:205-217.
24. Halliday GM, Flowers D, Baum L: Analysis of staining methods for different cortical plaques in Alzheimer’s disease. Acta Neuropathoi 1994;87:174-186.
25. Halliday GM, Davies L, McRitchic DA, Cartwright H, Pamphlctt R, Morris JGL: Ubiqui-tin-positive achromatic neurons incorticobasal degeneration. Acta Ncuropathol 1995;90:68-75.
26. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
27. de Vos RAI, Jansen ENH, Stam FC, Ravid R, Swaab DF: ‘Lewy body disease’; Clinico-pathological correlations in 18 consecutive cases of Parkinson’s disease with and without dementia. Clin Neurol Neurosurg 1995,97:13-22.
28. dc la Monte SM, Wells SE, Hcdley-Whytc T, Growdon JH: Neuropathological distinction between Parkinson'sdementiaand Parkinson’s plus Alzheimer’s disease. Ann Neurol 1989;26: 309-320.
29. Innis R: Single-photon emission tomography imaging of dopamine terminal innervation: A potential clinical tool in Parkinson’s disease. EurJNuclMcd 1994;21:1-5.
30. Lichter DG, Corbett AJ, Fitzgibbon GM, Davidson OR, Hope JKA, Goddard GV, Sharpies KJ, Pollock M: Cognitive and motor dysfunction in Parkinson’s disease. Clinical, performance, and computed tomographic correlations. Arch Neurol 1988;45:854-860.
31. Olanow C: Magnetic resonance imaging in parkinsonism. Neurol Clin 1992;10:405-420.
32. Neary D, Snowden JS, Mann DMA: The clinical pathological correlates of lobar atrophy. Dementia 1993;4:154-159.
33. The Lund and Manchester Groups: Clinical and neuropathological criteria for frontotem-poral dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
34. Dubois B, Pillon B, Stemic N, Lhermitte F, Agid Y: Age-induced cognitive disturbances in Parkinson’s disease. Neurology 1990:40:38-41.
35. Duncombe ME, Bradshaw JL, Iansek R, Phillips JG: Parkinsonian patients without dementia or depression do not suffer from bradyphrc-nia as indexed by performance in mental rotation tasks with and without advance information. Ncuropsychologica 1994;32:1383-1386.
36. dc la Monte SM, Wands JR: Diagnostic utility of quantitating neurofilamcnl-immunorcactivc Alzheimer's disease lesions. J Histochcm Cyto-chem 1994;42:1625-1634.
37. Mann D, Snowden J: The topographic distribution of brain atrophy in cortical Lewy body disease - comparison with Alzheimer's disease. Acta Neuropathoi 1995;89:178-183.
38. Förstl H, Bums A, Luthert P, Caims N, Levy R: The Lcwy-body variant of Alzheimer’s disease. Clinical and pathological findings. Br J Psychiatry 1993;162:385-392.
39. Samuel W, Galasko D, Masliah E, Hansen LA: Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;55:44-52.
40. Golorab J, Kluger A, de Leon MJ, Ferris SH, Convit A, Mittelman MS, Cohen J, Rusinck H, De Santi S, George AH: Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem 1994;1:45-54.
41. Owen AM, Sahakian BJ, Scmplc J, Polkcy CE. RobbinsTW: Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampcctomy in man. Neuropsychologica 1995;33:1-24.
42. Brown RG, Marsden CD: Cognitive function in Parkinson's disease: From description to theory. Trends Neurosci 1990:13:21-29.
43. Robbins TW, James M, Owen AM, Lange KW, Lees AJ, Leigh PN, Marsden CD, Quinn NP, Summers BA: Cognitive deficits in progressive supranuclear palsy. Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Ncurosurg Psychiatry 1994;57:79-88.
44. Allain H, Licurv A, Qucmener V, Thomas V, Reymann J-M, Gandon J-M: Procedural memoryand Parkinson's disease. Dementia 1995:6: 174-178.
45. Bondi MW, Kaszniak AW: Implicit and explicit memory in Alzheimer's disease and Parkinson's disease. J Clin Exp Ncuropsvchol 1991: 13:339-358.
46. Jellinger KA, Braak H, Braak E, Fischer P: Alzheimer lesions in the entorhinal region and iso-cortex in Parkinson's and Alzheimer's diseases. Ann NY Acad Sei 1991:640:203-209.
47. Bancher C, Braak H, Fischer P, Jellinger KA: Neuropalhological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993: 162:179-182.
48. Smith MC, Mallory M, Hansen LA, Ge N, Masliah E: Fragmentation of the neuronal cv-toskeleton in the Lewy body variant of Alzheimer's disease. Neurorcporl 1995:6:673-676.
49. Owen AM, Roberts AC, Hodges JR, Summers BA, Polkcy CE, Robbins TW: Contrasting mechanisms of impaired attcntional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993:116:1159-1175.
50. Jellinger KA: Pathology of Parkinson's disease, Changes other than the nigroslriatal pathway. MolChem Neuropathol 1991:14:153-197.
51. Eckcnstcin FP, Baughman RW, Quinn J: An anatomical study of cholinergic innervation in rat cerebral cortex. Neuroscience 1988:25:457-474.
52. Gasbarri A, Vemey C, Innocenzi R, Campana E, Pacitti C: Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: A combined retrograde tracing and immunohistochcmical study. Brain Res 1994: 668:71-79.